E2212
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for E2212, covering 2013-05-22 to 2013-05-22. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled, Sequential Ascending, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2212 in Healthy Subjects [Phase 1]